Tag: Pfizer

Facebook Bans Taliban Supporting Content
FB Expands Fight Against Covid Vax Misinformation To Include Kids

Facebook will also remove any claim that Covid-19 vaccines can kill or seriously harm kids, that they are not effective for children at all, and that anything other than a Covid-19 vaccine can inoculate children against the virus.

  • Sunday, 31 October 2021
US FDA Panel Okays Pfizer Covid Vax For Kids Aged 5-11
US FDA Panel Okays Pfizer Covid Vax For Kids Aged 5-11

"Covid-19 is "the eighth-highest killer of kids in this age group over the past year,"

  • Wednesday, 27 October 2021
Pfizer Says Its Covid Vax 90.7% Effective In Kids Aged 5-11
Pfizer Says Its Covid Vax 90.7% Effective In Kids Aged 5-11

If authorised, Pfizer-BioNTech vaccine would be the first Covid-19 vaccine for younger children.

  • Saturday, 23 October 2021
Covid oral pill
Covid Oral Pill Could Be Ready By Year-End: Pfizer CEO

New York: US-based pharmaceutical major Pfizer’s Chief Executive Officer Albert Bourla said that the company’s Covid-19 oral antiviral pill, which is in early-stage trials, could be ready by the end…

  • Sunday, 02 May 2021
Pfizer Offers COVID-19 Vaccines At 'Not-For-Profit' Price In India
Pfizer Offers COVID-19 Vaccines At 'Not-For-Profit' Price In India

New Delhi: US pharma major Pfizer on Thursday offered to supply the Pfizer-BioNTech vaccine at a “not-for-profit” price, media reports have cited. The company had earlier said that it will…

  • Thursday, 22 April 2021
COVID-19-vaccine
Covid-19 vaccine: Pfizer CEO claims medicine could be ready by October

New York: Global pharmaceutical major Pfizer believes that a Covid-19 vaccine could be ready by the end of October, the company’s CEO Albert Bourla said. Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19 in collaboration with German mRNA company BioNTech. Bourla made the comments while […]

  • Friday, 16 April 2021
COVID-Vaccine
COVID-19 Vaccine Will Be Ready By Year End In 'Best Case Scenario': Pfizer

New York: Pfizer, which has struck a nearly $2 billion deal with the US government to deliver 100 million doses of a COVID-19 vaccine developed in collaboration with its German partner BioNTech, is hoping to seek regulatory approval for a vaccine “as early as October” this year and have a vaccine on the market by […]

  • Wednesday, 14 April 2021
COVID-19-Vaccine
Covid Vaccine: Pfizer, BioNTech Begin Late Stage Clinical Trials

New York: US-based Pfizer and German biotech firm BioNTech have announced the start of a late stage clinical trial of a Covid-19 vaccine jointly developed by the two companies. The Phase 2/3 study will involve up to 30,000 participants between 18 and 85 years of age, the two companies said on Monday. The vaccine candidate, […]

  • Wednesday, 14 April 2021
Trump
Trump Accuses FDA And Pfizer Of Withholding COVID-19 Vaccine Announcement Before Elections

Washington: US President Donald Trump on Monday accused the Food and Drug Administration (FDA) and Pfizer of withholding the announcement on COVID-19 vaccine before elections to prevent him from getting a “vaccine win”. The US Food and Drug Administration “and the Democrats didn’t want to have me get a Vaccine WIN, prior to the election, […]

  • Friday, 09 April 2021
Sensex Hits 43,000-Mark For First Time; Nifty Tops 12,600
Sensex Hits 43,000-Mark For First Time; Nifty Tops 12,600

Mumbai: Extending its winning streak for the seventh straight session, equity benchmark Sensex soared 680 points to scale another lifetime high on Tuesday, tracking a global market rally driven by Pfizer’s COVID-19 vaccine trials data. After touching its lifetime peak of 43,316.44 during the day, the 30-share BSE index ended 680.22 points or 1.60 per […]

  • Friday, 09 April 2021
Coronavirus
Indian Vaccines Don't Need Temperature As Low As Pfizer's: AIIMS Director

New Delhi: Indian vaccines offer a lot of hope, due to various factors including a good safety signal, display of immunogenicity and capability of using the current storage infrastructure, said AIIMS Director Randeep Guleria in an exclusive interview with IANS. Recently, drug company Pfizer announced that its vaccine candidate for Covid-19 is more than 90 […]

  • Friday, 09 April 2021
Pfizer
Pfizer COVID19 Vaccine 95% Effective, Seeks Emergency Clearance

New York: Pfizer and its German partner BioNTech released a second batch of interim results on Wednesday, saying their coronavirus vaccine candidate is 95 per cent effective and also protects the most vulnerable people in older age groups from the risk of falling prey to the virus. “Primary efficacy analysis demonstrates BNT162b2 to be 95 […]

  • Friday, 09 April 2021
Oxford Covid-19 Vaccine ‘Encouraging' For Older Age Groups
Covid-19 Vaccine: Odisha May Face Cold Chain Challenge

Bhubaneswar: Even as the race of potential vaccine for Covid-19 is approaching the last lap, the cold-chain infrastructure is likely to emerge as biggest hurdle for Odisha, say experts. The State government has started a road map in full swing for procurement, preservation and distribution of the vaccine as Prime Minister Narendra Modi on Friday […]

  • Friday, 09 April 2021
Pfizer
First Americans 'Could Get Vaccine On December 11th': White House Vaccine Chief

Washington: The first Americans to receive a COVID-19 vaccine could get it as soon as December 11 or 12, the White House vaccine czar said on Sunday. On Friday, American pharmaceutical giant Pfizer and its German partner BioNTech submitted an application to the US Food and Drug Administration for emergency use authorisation for its COVID-19 […]

  • Friday, 09 April 2021
COVID Vaccine
Pfizer Seeks Emergency Use Authorisation For Its COVID-19 Vaccine In India

New Delhi: Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India (DCGI) an emergency use authorisation for its COVID-19 vaccine in the country, after its parent company secured such clearance in the UK and Bahrain. The firm, in its application submitted to the drug regulator, has sought permission […]

  • Thursday, 08 April 2021
scrollToTop